Expression of Apo-3 and Apo-3L in primitive neuroectodermal tumours of the central and peripheral nervous system
- 1 January 2002
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 38 (1), 92-98
- https://doi.org/10.1016/s0959-8049(01)00347-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Requirement for the CD95 Receptor-Ligand Pathway in c-Myc-Induced ApoptosisScience, 1997
- LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicingProceedings of the National Academy of Sciences of the United States of America, 1997
- Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κBCurrent Biology, 1996
- The killer and the executioner: how apoptosis controls malignancyCurrent Opinion in Immunology, 1995
- A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeCell, 1995
- Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastomaMedical and Pediatric Oncology, 1995
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Histopathologic Prognostic Factors in Neuroblastic Tumors: Definition of Subtypes of Ganglioneuroblastoma and an Age-Linked Classification of NeuroblastomasJNCI Journal of the National Cancer Institute, 1984
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984